2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the …

C Vrints, F Andreotti, KC Koskinas… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management—the plaque hypothesis: a narrative …

PH Stone, P Libby, WE Boden - JAMA cardiology, 2023 - jamanetwork.com
Importance Recent clinical and imaging studies underscore that major adverse cardiac
events (MACE) outcomes are associated not solely with severe coronary obstructions …

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association …

Writing Committee Members, SS Virani… - Journal of the American …, 2023 - jacc.org
Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

[HTML][HTML] Timing of complete revascularization with multivessel PCI for myocardial infarction

BE Stähli, F Varbella, A Linke, B Schwarz… - … England Journal of …, 2023 - Mass Medical Soc
Background In patients with ST-segment elevation myocardial infarction (STEMI) with
multivessel coronary artery disease, the time at which complete revascularization of …

Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective …

R Diletti, WK den Dekker, J Bennett, CE Schotborgh… - The Lancet, 2023 - thelancet.com
Background In patients with acute coronary syndrome and multivessel coronary disease,
complete revascularisation by percutaneous coronary intervention (PCI) is associated with …

Optical coherence tomography–guided or intravascular ultrasound–guided percutaneous coronary intervention: the OCTIVUS randomized clinical trial

DY Kang, JM Ahn, SC Yun, SH Hur, YK Cho, CH Lee… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Intravascular imaging–guided percutaneous coronary intervention (PCI)
with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) showed …

[HTML][HTML] Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research

P Gaba, BJ Gersh, J Muller, J Narula… - Nature Reviews …, 2023 - nature.com
Understanding the natural history of coronary artery atherosclerosis is necessary to
determine prognosis and prescribe effective therapies. Traditional management of coronary …

[HTML][HTML] Routine functional testing or standard care in high-risk patients after PCI

DW Park, DY Kang, JM Ahn, SC Yun… - … England Journal of …, 2022 - Mass Medical Soc
Background There are limited data from randomized trials to guide a specific follow-up
surveillance approach after myocardial revascularization. Whether a follow-up strategy that …

Clinical quantitative coronary artery stenosis and coronary atherosclerosis imaging: a Consensus Statement from the Quantitative Cardiovascular Imaging Study …

AJV Mézquita, F Biavati, V Falk, H Alkadhi… - Nature Reviews …, 2023 - nature.com
The detection and characterization of coronary artery stenosis and atherosclerosis using
imaging tools are key for clinical decision-making in patients with known or suspected …

[HTML][HTML] The Treatment of Coronary Artery Disease: Current Status Six Decades After the First Bypass Operation

T Doenst, H Thiele, J Haasenritter… - Deutsches Ärzteblatt …, 2022 - ncbi.nlm.nih.gov
Background The first coronary artery bypass operation (CABG) was performed on May 2,
1960. The first percutaneous coronary intervention (PCI) was performed almost 20 years …